Literature DB >> 12422328

Eccentric contraction injury in dystrophic canine muscle.

Martin K Childers1, Carol S Okamura, Daniel J Bogan, Janet R Bogan, Gregory F Petroski, Kerry McDonald, Joe N Kornegay.   

Abstract

OBJECTIVE: To test the hypothesis that eccentric contractions induce greater injury in dystrophic compared with normal canine muscle.
DESIGN: Blinded cohort study.
SETTING: Animal laboratory. ANIMALS: Ten dogs with a homologue to Duchenne muscular dystrophy (Golden retriever muscular dystrophy [GRMD]) and 10 normal littermates.
INTERVENTIONS: Contractions induced in tibiotarsal flexors and extensors by sciatic nerve stimulation. Because more powerful extensors overrode flexors, eccentric contractions occurred in flexors. Concentric contractions were induced in contralateral flexors by peroneal nerve stimulation. MAIN OUTCOME MEASURE: Tibiotarsal flexion force 3 days after contractions. Muscle was examined for injury (esterase activity, Evans blue dye penetration) and regeneration (embryonic myosin isoform expression).
RESULTS: Mean force deficit after eccentric flexor contractions was 43.3%+/-25.7% in GRMD dogs compared with 25.0%+/-18.4% in controls (P=.04, Wilcoxon rank-sum test). Concentric contractions induced force deficits in GRMD but not normal dogs; however, the difference between the 2 groups was not significant (P=.08, Wilcoxon rank-sum test). After concentric contractions in controls, force decrements correlated with esterase activity measured by area (r=.794, P=.006) and intensity (r=.697, P=.025, Spearman rank correlation). No other significant correlation was detected between force and biopsy data.
CONCLUSIONS: Force data support the hypothesis that eccentric contractions induce greater injury in dystrophic compared with normal canine muscle. Phenotypic features of the dystrophic canine model used here are similar to those of humans with Duchenne's. Copyright 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422328     DOI: 10.1053/apmr.2002.35109

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  17 in total

1.  In vivo canine muscle function assay.

Authors:  Martin K Childers; Robert W Grange; Joe N Kornegay
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

Review 2.  Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy.

Authors:  John M Lawler
Journal:  J Physiol       Date:  2011-03-08       Impact factor: 5.182

Review 3.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 4.  What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2019-07-09       Impact factor: 2.698

5.  Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs.

Authors:  Christopher J Tegeler; Robert W Grange; Daniel J Bogan; Chad D Markert; Doug Case; Joe N Kornegay; Martin K Childers
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

6.  Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Jeffrey J Widrick; Matthew S Alexander; Benjamin Sanchez; Devin E Gibbs; Genri Kawahara; Alan H Beggs; Louis M Kunkel
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

7.  Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Authors:  Xuan Guan; David L Mack; Claudia M Moreno; Jennifer L Strande; Julie Mathieu; Yingai Shi; Chad D Markert; Zejing Wang; Guihua Liu; Michael W Lawlor; Emily C Moorefield; Tara N Jones; James A Fugate; Mark E Furth; Charles E Murry; Hannele Ruohola-Baker; Yuanyuan Zhang; Luis F Santana; Martin K Childers
Journal:  Stem Cell Res       Date:  2013-12-23       Impact factor: 2.020

8.  Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology.

Authors:  Stefan M Gehrig; René Koopman; Timur Naim; Clarissa Tjoakarfa; Gordon S Lynch
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

Review 9.  Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy.

Authors:  Jong-Hee Kim; Hyo-Bum Kwak; LaDora V Thompson; John M Lawler
Journal:  J Muscle Res Cell Motil       Date:  2012-10-28       Impact factor: 2.698

10.  The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice.

Authors:  James A Ridgley; Gavin J Pinniger; Peter W Hamer; Miranda D Grounds
Journal:  Pflugers Arch       Date:  2008-08-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.